Effect of Sodium Bicarbonate Mouth Wash on Salivary pH and Interleukin-1β Levels among SmokersFunding None.
Objective Smoking induces changes in salivary pH and inflammatory biomarker levels associated with oral diseases. This study examined the effect of alkaline oral rinse to modify this effect of smoking on salivary study parameters.
Materials and Methods A double-blind randomized controlled trial (RCT) on systemically healthy smokers was conducted. A total of 78 smokers, aged 18 to 40 years, were enrolled as per exclusion/inclusion criteria. An alkaline mouthwash was provided to the intervention group and a placebo to control group. Salivary pH and inflammatory biomarker interleukin (IL)-1β levels were evaluated at baseline and at follow-up (14 ± 2 days).
Statistical Analysis Chi-squared test, independaent t-test, and paired t-test were used to observe the changes in parameters among and between groups before and after intervention using SPSS v16 with a significance level of p≤0.050.
Results Sixty eight salivary samples were analyzed. All study parameters of the study sample were statistically insignificant between both intervention and control groups at baseline. pH level was 6.56 ± 0.53 at baseline and 6.62 ± 0.45 at follow-up in the intervention group; respective values for control group were 6.70 ± 0.36 and 6.83 ± 0.44 and the changes were not significant (p≥0.071). IL-1β level was 9.39 ± 10.23 pg/µL at baseline and 5.40 ± 6.62 pg/µL at a follow-up in the intervention group and the change was significant (p = 0.001); respective values for the control group were 10.63 ± 11.50, and 9.33 ± 11.73 and the difference was nonsignificant (p = 0.076).
Conclusion This randomized trial indicated that sodium bicarbonate mouth rinse is effective in decreasing IL-1β levels and increasing salivary pH favorable for prevention of oral diseases.
12 May 2020 (online)
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
- 1 Marsh PD. Microbial ecology of dental plaque and its significance in health and disease. Adv Dent Res 1994; 8 (02) 263-271
- 2 Tenovuo J. Salivary parameters of relevance for assessing caries activity in individuals and populations. Community Dent Oral Epidemiol 1997; 25 (01) 82-86
- 3 Khurshid Z, Naseem M, Sheikh Z, Najeeb S, Shahab S, Zafar MS. Oral antimicrobial peptides: types and role in the oral cavity. Saudi Pharm J 2016; 24 (05) 515-524
- 4 Cogulu D, Sabah E, Kutukculer N, Ozkinay F. Evaluation of the relationship between caries indices and salivary secretory IgA, salivary pH, buffering capacity and flow rate in children with Down’s syndrome. Arch Oral Biol 2006; 51 (01) 23-28
- 5 Grover N, Sharma J, Sengupta S, Singh S, Singh N, Kaur H. Long-term effect of tobacco on unstimulated salivary pH. J Oral Maxillofac Pathol 2016; 20 (01) 16-19
- 6 Foglio-Bonda A, Pattarino F, Foglio-Bonda PL. Kinematic viscosity of unstimulated whole saliva in healthy young adults. Eur Rev Med Pharmacol Sci 2014; 18 (20) 2988-2994
- 7 Chandel S, Khan MA, Singh N, Agrawal A, Khare V. The effect of sodium bicarbonate oral rinse on salivary pH and oral microflora: a prospective cohort study. Natl J Maxillofac Surg 2017; 8 (02) 106-109
- 8 Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342 (12) 836-843
- 9 Gomes SC, Abascal CC, Haas AN, Angst PDM, Oppermann RV, Marcantonio RA. Influence of supragingival biofilm control and smoking habit on Interleukin-1βconcentration. Braz Oral Res 2015; 29 (01) S1806-83242015000100302
- 10 Helmersson J, Larsson A, Vessby B, Basu S. Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis 2005; 181 (01) 201-207
- 11 Liu J, Liang Q, Frost-Pineda K. et al. Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers. Cancer Epidemiol Biomarkers Prev 2011; 20 (08) 1760-1769
- 12 Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010; 34 (03) J258-J265
- 13 Ouchida R, Mori H, Hase K. et al. Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses. Proc Natl Acad Sci U S A 2012; 109 (40) E2699-E2706
- 14 Khurshid Z, Zohaib S, Najeeb S, Zafar MS, Slowey PD, Almas K. Human saliva collection devices for proteomics: an update. Int J Mol Sci 2016; 17 (06) 846-854
- 15 Sahibzada HA, Khurshid Z, Khan RS. et al. Salivary IL-8, IL-6 and TNF-αas potential diagnostic biomarkers for oral cancer. Diagnostics (Basel) 2017; 7 (02) 21-26
- 16 Khurshid Z. Salivary point-of-care technology. Eur J Dent 2018; 12 (01) 1-2
- 17 Rangbulla V, Nirola A, Gupta M, Batra P, Gupta M. Salivary IgA, interleukin-1β and MMP-8 as salivary biomarkers in chronic periodontitis patients. Chin J Dent Res 2017; 20 (01) 43-51
- 18 Rivera-Hidalgo F. Smoking and periodontal disease. Periodontol 2000 2003; 32: 50-58
- 19 Vellappally S, Fiala Z, Smejkalová J, Jacob V, Somanathan R. Smoking related systemic and oral diseases. Acta Med (Hradec Kralove) 2007; 50 (03) 161-166
- 20 Michaud DS, Fu Z, Shi J, Chung M. Periodontal disease, tooth loss, and cancer risk. Epidemiol Rev 2017; 39 (01) 49-58
- 21 Lindson-Hawley N, Hartmann-Boyce J, Fanshawe TR, Begh R, Farley A, Lancaster T. Interventions to reduce harm from continued tobacco use. Cochrane Database Syst Rev 2016; 10: CD005231
- 22 Reibel J. Tobacco and oral diseases. Update on the evidence, with recommendations. Med Princ Pract 2003; 12 (Suppl. 01) 22-32
- 23 Rehan F, Khan RS, Memon MS, Naqvi S. Analysis of resting mouth salivary flow rate and salivary pH of tobacco chewers and smokers. J Pak Dent Assoc 2016; 25 (04) 159-163
- 24 Nagler R, Savulescu D, Gavish M. Cigarette smoke-induced reduction in binding of the salivary translocator protein is not mediated by free radicals. Biochimie 2016; 121: 1-4
- 25 Aguilar-Zinser V, Irigoyen ME, Rivera G, Maupomé G, Sánchez-Pérez L, Velázquez C. Cigarette smoking and dental caries among professional truck drivers in Mexico. Caries Res 2008; 42 (04) 255-262
- 26 Bayraktar G, Kazancioglu R, Bozfakioglu S, Ecder T, Yildiz A, Ark E. Stimulated salivary flow rate in chronic hemodialysis patients. Nephron 2002; 91 (02) 210-214
- 27 Martins Mussi MC, Moffa E, Castro T. et al. Salivary parameters and oral health in the Moebius syndrome. Spec Care Dentist 2016; 36 (05) 265-270
- 28 Hay DI. Salivary factors in caries models. Adv Dent Res 1995; 9 (03) 239-243
- 29 Ata-Ali J, Flichy-Fernández AJ, Alegre-Domingo T, Ata-Ali F, Peñarrocha-Diago M. Impact of heavy smoking on the clinical, microbiological and immunological parameters of patients with dental implants: a prospective cross-sectional study. J Investig Clin Dent 2016; 7 (04) 401-409
- 30 Hou LT, Liu CM, Liu BY, Lin SJ, Liao CS, Rossomando EF. Interleukin-1beta, clinical parameters and matched cellular-histopathologic changes of biopsied gingival tissue from periodontitis patients. J Periodontal Res 2003; 38 (03) 247-254
- 31 Suzuki N, Nakanishi K, Yoneda M, Hirofuji T, Hanioka T. Relationship between salivary stress biomarker levels and cigarette smoking in healthy young adults: an exploratory analysis. Tob Induc Dis 2016; 14: 20
- 32 Krall EA, Dawson-Hughes B, Garvey AJ, Garcia RI. Smoking, smoking cessation, and tooth loss. J Dent Res 1997; 76 (10) 1653-1659
- 33 Ojima M, Hanioka T, Tanaka K, Aoyama H. Cigarette smoking and tooth loss experience among young adults: a national record linkage study. BMC Public Health 2007; 7: 313
- 34 Albandar JM, Rams TE. Global epidemiology of periodontal diseases: an overview. Periodontol 2000 2002; 29: 7-10
- 35 Kim TH, Kim SJ, Lee SM. Stimulation of the 7 nicotinic acetylcholine receptor protects against sepsis by inhibiting toll-like receptor via phosphoinositide 3-kinase activation. J Infect Dis 2014; 209 (10) 1668-1677
- 36 Cui WY, Li MD. Nicotinic modulation of innate immune pathways via α7 nicotinic acetylcholine receptor. J Neuroimmune Pharmacol 2010; 5 (04) 479-488